Intratumoral PD‐L2 expression in colorectal cancer,[14] glioma,[15] and prostate cancer,[16] and intratumoral FasL expression in gastric cancer,[17] breast cancer,[18] and esophageal squamous‐cell carcinoma[19] are commonly observed. The gene discussed is FASLG; the disease is prostate carcinoma.